A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass index, that could change clinical care.

The condition is better measured by looking at factors like inflammation, insulin resistance, and glucose tolerance, according to the doctor. In some cases, using BMI can result in “muscular athletes” being labeled as obese, he noted, and people with “normal” BMI can sometimes have “harmful” levels of visceral (abdominal) fat.

Researchers at the, Riverside, backed by a substantial NIH grant, are pioneering a study on the unique immune responses to obesity and parasitic infections, highlighting differences between males and females.

New guidance from a team of health experts around the world proposes expanding the definition of obesity beyond the popular body mass index (BMI) measure.

As of March 2020, nearly 42% of U.S. adults had obesity, according to the CDC. Athletes and people who are very fit, like Kelce and Gyllenhaal, may have a higher BMI because muscle typically weighs more than fat. But that doesn't make them unhealthy.

According to a September 2024 data brief from the Centers for Disease Control and Prevention (CDC), 40.3 percent of U.S. adults were considered obese between August 2021 and August 2023.

A group of experts from around the world are proposing an alternative way of defining clinical obesity, eschewing the commonly referenced body max index (BMI) and instead approaching the condition

A new report published Monday found that heart disease continues to be the leading cause of death in the United States.

Speaking about obesity and diabetes, RFK Jr. said he would rather provide people with organic food three times a day than hemorrhage trillions of dollars on Ozempic shots.

Maps show the U.S. states with the healthiest diets, based on fruit and vegetables, alcohol, food insecurity, and diseases.

In recent decades, the health of the average American has steadily declined: obesity rates have tripled since the 60s, while diabetes has nearly quadrupled since the 80s. Central to the

Data from a Phase Ia single ascending dose study found that ASC30 demonstrated dose-proportional pharmacokinetics, a half-life of up to 60 hours, and superior pharmacokinetic properties compared to other oral GLP-1 receptor agonists.